Exir Redeka Ltd. imports quality products from reputable manufacturers in Molecular Biology, Pathology, Lab. Automation and Robotics also unique products in Rapid Diagnostics and related areas in the field of Medicine, Pharmaceutical and Food industries. Exir Redeka Ltd. partners multinational companies such as BioGenex Inc. USA, NanoRepro AG Germany and Xiril AG Switzerland to offer technology of the day and unique services.
Market Research Report : In vitro diagnostics market in india 2014 - SampleNetscribes, Inc.
The document discusses the in vitro diagnostics market in India. It notes that the market was valued at INR 'a' billion in 20-- and is expected to grow at a CAGR of x% to reach INR 'f' billion by 20--. Segment 1 and Segment 2 are currently the largest contributors to the market. Key drivers of market growth include rising disease prevalence, increased healthcare access and awareness. The market remains heavily import-dependent for instruments but demand for reagents is growing. Leading trends include increased automation and point-of-care testing technologies. Major players in the market include several domestic and multinational companies.
Thyrocare Technologies Limited claims to be India’s most advanced totally automated laboratory having its strong presence in more than 2000 cities / towns in India and internationally.
The company was started in 1996, by Dr Velumani Arokiaswamy with a staff of 4 people, with focus on low cost Thyroid testing.
By 2014, it has become India’s most profitable diagnostic business. The company has a highly differentiated business model. It is more of a B2B company, collecting samples from hundreds of dedicated collection points, and also from allied labs. All processing is done in one highly automated lab near Mumbai.
Medical & Pharmaceutical Trends Impacting The Chemicals And Materials Ind...stevelmy
The document discusses trends in the medical and pharmaceutical industries and their impact on the chemicals and materials sector. It covers how the economic downturn has affected different industry segments, with healthcare outperforming other sectors. The presentation examines materials used in medical devices and chemical excipients for drugs. It identifies winners and losers during the downturn and discusses strategies for companies, noting opportunities for plastics suppliers in medical devices and the need for specialty chemical firms to partner with more pharmaceutical companies.
Oppi Ey Report Unlocking The Potential Of The Pharma Distribution Channelhealthcaremanas
The document discusses unlocking the potential of the pharmaceutical distribution channel in India. A survey was conducted of pharmaceutical companies, distributors, and retailers. Key findings include: sales are being lost due to ineffectiveness of the post-CFA supply chain in making products available to consumers; and excess inventory levels and month-end inventory skews exist due to inefficiencies in the supply chain. The implications for the industry are that distribution needs to be strategically leveraged for growth rather than seen as an operational function alone. Potential solutions and their benefits are outlined.
A start-up with a difference - we make advertising that sells! Print, outdoor, TV, events, website, mobile apps, digital, social - consistent message through all media!....a veritable 'One Stop Shop for all your branding, communications, creative & promotional needs.
This document summarizes a webinar on launching products in India. It introduces representatives from Becton Dickinson India and Apollo Hospitals who discuss their perspectives on distribution and working with hospitals. Key challenges of the Indian market include its large size and fragmentation requiring multi-tier distribution networks. Success requires understanding customer needs, having the right KPIs, building relationships with distributors, and commitment to adapting to the local market. The hospital perspective emphasizes landscape research, solving clear problems, considering alternatives, and adapting to the market.
Market Research Report : In vitro diagnostics market in india 2014 - SampleNetscribes, Inc.
The document discusses the in vitro diagnostics market in India. It notes that the market was valued at INR 'a' billion in 20-- and is expected to grow at a CAGR of x% to reach INR 'f' billion by 20--. Segment 1 and Segment 2 are currently the largest contributors to the market. Key drivers of market growth include rising disease prevalence, increased healthcare access and awareness. The market remains heavily import-dependent for instruments but demand for reagents is growing. Leading trends include increased automation and point-of-care testing technologies. Major players in the market include several domestic and multinational companies.
Thyrocare Technologies Limited claims to be India’s most advanced totally automated laboratory having its strong presence in more than 2000 cities / towns in India and internationally.
The company was started in 1996, by Dr Velumani Arokiaswamy with a staff of 4 people, with focus on low cost Thyroid testing.
By 2014, it has become India’s most profitable diagnostic business. The company has a highly differentiated business model. It is more of a B2B company, collecting samples from hundreds of dedicated collection points, and also from allied labs. All processing is done in one highly automated lab near Mumbai.
Medical & Pharmaceutical Trends Impacting The Chemicals And Materials Ind...stevelmy
The document discusses trends in the medical and pharmaceutical industries and their impact on the chemicals and materials sector. It covers how the economic downturn has affected different industry segments, with healthcare outperforming other sectors. The presentation examines materials used in medical devices and chemical excipients for drugs. It identifies winners and losers during the downturn and discusses strategies for companies, noting opportunities for plastics suppliers in medical devices and the need for specialty chemical firms to partner with more pharmaceutical companies.
Oppi Ey Report Unlocking The Potential Of The Pharma Distribution Channelhealthcaremanas
The document discusses unlocking the potential of the pharmaceutical distribution channel in India. A survey was conducted of pharmaceutical companies, distributors, and retailers. Key findings include: sales are being lost due to ineffectiveness of the post-CFA supply chain in making products available to consumers; and excess inventory levels and month-end inventory skews exist due to inefficiencies in the supply chain. The implications for the industry are that distribution needs to be strategically leveraged for growth rather than seen as an operational function alone. Potential solutions and their benefits are outlined.
A start-up with a difference - we make advertising that sells! Print, outdoor, TV, events, website, mobile apps, digital, social - consistent message through all media!....a veritable 'One Stop Shop for all your branding, communications, creative & promotional needs.
This document summarizes a webinar on launching products in India. It introduces representatives from Becton Dickinson India and Apollo Hospitals who discuss their perspectives on distribution and working with hospitals. Key challenges of the Indian market include its large size and fragmentation requiring multi-tier distribution networks. Success requires understanding customer needs, having the right KPIs, building relationships with distributors, and commitment to adapting to the local market. The hospital perspective emphasizes landscape research, solving clear problems, considering alternatives, and adapting to the market.
Sweet Sensors describes small, inexpensive diagnostic devices that can detect a variety of biological markers through quantitative tests adapted to many targets, including recreational drugs, heavy metals, toxins, bacteria, viruses, pharmaceuticals, and environmental and food safety hazards. The devices are described as having small form factors and being able to detect targets through adaptable tests in a quantitative manner.
Global Impact Of Sunshine Act June 7 8 Philadelphia Yavuz Silay MD,MBAYavuz Silay
This document announces a conference to help pharmaceutical and medical device companies comply with the Physician Payments Sunshine Act. The conference will provide information on the new regulations, best practices for data collection and reporting, challenges physicians may face with additional transparency, and how to determine what payments must be reported. It encourages compliance professionals in areas like regulatory affairs, government relations, and marketing to attend in order to accurately report payments and gifts to physicians as required by law.
- Jeff Campbell, EVP and CFO of McKesson, presented at the UBS Healthcare Conference on February 8, 2012.
- McKesson is well-positioned for growth through leading market positions, a focus on higher margin businesses, and linking their distribution and technology segments.
- Their diversified portfolio across providers, payers, and connectivity provides a platform for steady long-term growth.
Market Research Report : Medical diagnostics market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract :
Netscribes’ latest market research report titled Medical Diagnostics Market in India 2014 analyses the growth of the market due to cutting edge technology which provides better disease diagnosis. The Indian diagnostics market can be divided into equipment, reagents and services. The service sector is characterized by a large number of laboratories in the unorganized sector, which are clustered in the suburban areas and metros. In order to have better regulations and proper definition for the market a clear and structured format is being established. The laboratories are rapidly expanding using various business models. Large numbers of laboratories are registered only with the state health departments and not recognized by NABL (National Accreditation Board for Testing and Calibration Laboratories under Department of Science and Technology, Govt. of India).
The market is driven by increasing number of lifestyle diseases, rise in life expectancy due to preventive healthcare practices and increasing medical tourism. Currently there is trend of diagnostic medical imaging due to innovation in the technology sector which is helping the market to grow. Few numbers of accredited labs and high dependence on imported medical diagnostics products are the challenges this market is facing. Even though a range of diagnostic tests for various diseases are available in the market, there is a need for more reliable and better diagnostics. The market is dominated by private diagnostics companies in India who are expanding in Tier I and Tier II cities. Providing after-sales services for medical instruments and competitive pricing of the tests will catalyze the growth of the diagnostic sector.
Table of Contents :
Slide 1: Executive Summary
Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 – Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 – Jul 2013), Exchange Rate: Half Yearly (Aug 2013 – Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)
Introduction
Slide 5: Medical Diagnostics Sector – Overview
Market Overview
Slide 6: Medical Diagnostics– Market Overview Forecasted Market Size and Growth (Value-Wise; 2013 – 2018e)
Slide 7: Medical Diagnostics Market – Overview of Franchise Business Model
Slide 8: Medical Diagnostics Market – Overview of Other Business Models
Slide 9: Accreditation of Laboratories
Slide 10: Technological Developments Used for the Diagnosis of a Wide Spectrum of Infectious Diseases
Drivers & Challenges
Slide 11: Medical Diagnostics Market – Drivers and Challenges summary
Slide 12-16: Drivers
Slide 17-18: Challenges
Trends
Slide 19: Trends – Summary
Slide 20-22: Trends
Go
Letícia | Phone: 55 (21) 4009-0276 | E-mail: leticia@profarma.com.br
Market Maker: BTG Pactual | Phone: 55 (11) 3383-2384
Ticker: BM&FBOVESPA: PRMX3
Independent Auditors: KPMG
Thank you for your interest in Profarma. Please contact us if you have any other questions.
Healthcare Reform & Physician Loyalty: What Can CRM Do To Support ACOs?Perficient, Inc.
Martin Sizemore, Enterprise Architect at Perficient, and Lisa Anderson, CRM Solution Architect at Perficient, discuss Consumerism in Healthcare, Physician Practice Challenges & Alignment, and provide a Physician Loyalty Campaign Demo
The healthcare sector in India is governed by the Ministry of Health and Family Welfare. It has a total value of more than $40 billion and employs 8 million people directly and indirectly. Between 2000-2011, the sector grew by 9.8% annually. However, corporate hospitals constitute less than 1% of all healthcare institutes. An investment of $14.4 billion is needed by 2025 to increase India's bed density to at least two per thousand population.
MarketsandMarkets is a global market research firm that publishes strategically analyzed market research reports to help Fortune 500 companies make better business decisions. They offer a wide range of market research services including syndicated reports, consulting services, and custom research. MarketsandMarkets aims to provide actionable business insights into key industries to assist clients with sustainable growth.
The document is a 2012 study by CapSite on health information exchange (HIE). It provides an overview of study participants' profiles, current HIE adoption rates and recent technology investments, future investment plans, primary HIE vendors used, factors considered in vendor selection, and accountability care strategies. The appendix describes CapSite as a healthcare technology research and advisory firm that provides strategic industry reports, voice of customer research, and other solutions to help clients make informed decisions.
Innovation in medical device and diagnostic industry at India Leadership Conc...Indian Affairs
Conceptualized& instituted in the year by India’s most respected journalist Satya Brahma, India Leadership Conclave Awards are are meant to highlight & celebrate those individuals & companies who’ve ascended to the top of their business against all odds. Currently celebrating its 9th successful annual editions, iconic figures such as Ratata Tata, MukeshAmbani, Naresh Goyal, Narayan Murthy, Shiv Nadar,SudhaMurthy,Priyanka Chopra, Manish Malhotra, Neeta Lulla, Late Yash Chopra, Govinda, Rani Mukerjee, Sushimita Sen, Karishma Kapoor are some of its proud recipients. Being India’s most iconic leadership awards having a tremendous impact on the credibility of the Group, India Leadership Conclave jury takes every steps to ensure fair, credible & independent selection process,.The nomination categories, eligibility criteria, selection process & evaluation criteria constitute the core areas of research. Public voting constitutes its biggest parameters. Physical interviews by Network 7 Media Group Journalists on ground on each nominee are conducted followed by Jury’s strong analytical verdict. The set of awards developed by the Board Members of the Network 7 Media Group is to propel the talent engine & encourage, motivate the innovative entrepreneurs. These leadership awards are aimed at empowering the leaders who think differently.This recognition voted by the people of india& subsequent by Jury Board reflect the Winner’s remarkable achievement & accomplishments as a leader of substance driven by passion, initiative & commitment to deliver excellence. India Leadership Conclave Awards are special as we don’t follow any traditional guidelines, defy conventions & crown winners based on innovations, merit & competence. Our decision is based on number of factors which are transparent, robust & driven by extensive research.
Where Right Brain Meets Left: Translating for Medical and Pharmaceutical Mark...Erin Lyons
Medical and pharmaceutical marketing and promotional translation is a highly specialized discipline requiring scientific understanding and the agility and resourcefulness of a creative wordsmith. Translations must be accurate and intelligible, but they must also be engaging and work within the framework of an existing brand personality and advertising platform. Participants will be given an overview of advertising and promotional material (print, television, sales aids) and technical input (product monographs, patient brochures, production-related documents). Specific exercises and examples will explore interlinguistic wordplay, language-specific tone and voice, and production and regulatory constraints.
MediProbe Consultancy Services Pvt. Ltd. is an industry leading and pioneering Medical Intelligence Company specializing in Insurance Claims Verification and also active in other allied disciplines. We at MediProbe use top notch, seasoned investigators with years of experience in fraud investigation who leave no stone unturned in their quest to find and expose the truth. We have till date helped save insurance companies Millions of rupees- an astronomical sum they would have lost to fraudulent claims without Mediprobe. The key to this success is our belief in quality and performance and we are proud to have the highest ratio of fraud detection and denial of wrongful/fraudulent claims with concrete evidence. We are the investigator of choice for most Insurance Companies and leading TPAs operating in India. The fact that the number of claim investigations assigned to us has shot up from a measly 60 cases per month just a year ago to over 250 cases per month as of today speaks volumes about our quality and efficiency.
Bear Stearns 2003 Global Healthcare Conference Presentationfinance2
John Hammergren, CEO of McKesson Corporation, presented at the 2003 Bear Stearns Global Healthcare Conference. He outlined McKesson's mission to advance healthcare and success of its partners. McKesson offers comprehensive products and services across pharmaceutical distribution, medical supplies, automation technology, and clinical software. McKesson aims to leverage its size, customer base, and solutions to create value for customers and shareholders through improved quality, reduced costs, and sustained financial performance across its business segments.
Market Research Report : Catheterization laboratory market in india 2014 - Sa...Netscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract:
Netscribes’ latest market research report titled Catheterization Laboratory Market in India 2014 states that the Indian market for catheterization laboratories is growing steadily as a result of the advancements in technology and the resultant increase in demand from hospitals, nursing homes and other medical centers. Different segments are available in the market which includes the premium, performance and value segments. The rising incidence of cardiac diseases in the country and the increasing need for various medical procedures conducted in cath labs is however the most important growth factor for the market. Due to the growing target base, that is, healthcare centers, the market has huge potential for growth, thereby bringing immense benefit to players.
Several technological trends are visible in the market. With the rapid advancement and development of newer technologies, the market will get a further boost. Both domestic and foreign companies operate in the market and high competitive rivalry exists between them. However, Philips, GE and Siemens cumulatively hold the highest share in the market. The expansion of hospitals in tier II and tier III cities will help the Indian companies as these centers generally have a budget constraint and would prefer to buy the products of domestic manufacturers who generally sell their products at a lower price than those of foreign manufacturers.
Table of Contrnts:
The document summarizes the finance department of Fortis Hospital. It outlines the hierarchy and roles within the finance department, including preparing budgets, managing investments, and evaluating hospital performance. It also discusses the hospital's sources of revenue, operating and capital expenses, taxes paid, and key performance indicators like bed occupancy, average length of stay, and average revenue per occupied bed. The presentation provides an overview of the hospital's financial operations and metrics.
Market Research Report : Coronary stents market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract:
Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Table of Contents:
Saudi Arabia Diagnostic Labs Market, Forecast and Opportunities, 2027_Report.pdfMarcoBrown12
Saudi Arabia Diagnostic Labs market stood at USD1546.81 million in 2021 and is expected to grow at a steady CAGR of 6.79% during the forecast period.
For more information, click here: https://www.techsciresearch.com/report/saudi-arabia-diagnostic-labs-market/7937.html
Sweet Sensors describes small, inexpensive diagnostic devices that can detect a variety of biological markers through quantitative tests adapted to many targets, including recreational drugs, heavy metals, toxins, bacteria, viruses, pharmaceuticals, and environmental and food safety hazards. The devices are described as having small form factors and being able to detect targets through adaptable tests in a quantitative manner.
Global Impact Of Sunshine Act June 7 8 Philadelphia Yavuz Silay MD,MBAYavuz Silay
This document announces a conference to help pharmaceutical and medical device companies comply with the Physician Payments Sunshine Act. The conference will provide information on the new regulations, best practices for data collection and reporting, challenges physicians may face with additional transparency, and how to determine what payments must be reported. It encourages compliance professionals in areas like regulatory affairs, government relations, and marketing to attend in order to accurately report payments and gifts to physicians as required by law.
- Jeff Campbell, EVP and CFO of McKesson, presented at the UBS Healthcare Conference on February 8, 2012.
- McKesson is well-positioned for growth through leading market positions, a focus on higher margin businesses, and linking their distribution and technology segments.
- Their diversified portfolio across providers, payers, and connectivity provides a platform for steady long-term growth.
Market Research Report : Medical diagnostics market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract :
Netscribes’ latest market research report titled Medical Diagnostics Market in India 2014 analyses the growth of the market due to cutting edge technology which provides better disease diagnosis. The Indian diagnostics market can be divided into equipment, reagents and services. The service sector is characterized by a large number of laboratories in the unorganized sector, which are clustered in the suburban areas and metros. In order to have better regulations and proper definition for the market a clear and structured format is being established. The laboratories are rapidly expanding using various business models. Large numbers of laboratories are registered only with the state health departments and not recognized by NABL (National Accreditation Board for Testing and Calibration Laboratories under Department of Science and Technology, Govt. of India).
The market is driven by increasing number of lifestyle diseases, rise in life expectancy due to preventive healthcare practices and increasing medical tourism. Currently there is trend of diagnostic medical imaging due to innovation in the technology sector which is helping the market to grow. Few numbers of accredited labs and high dependence on imported medical diagnostics products are the challenges this market is facing. Even though a range of diagnostic tests for various diseases are available in the market, there is a need for more reliable and better diagnostics. The market is dominated by private diagnostics companies in India who are expanding in Tier I and Tier II cities. Providing after-sales services for medical instruments and competitive pricing of the tests will catalyze the growth of the diagnostic sector.
Table of Contents :
Slide 1: Executive Summary
Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 – Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 – Jul 2013), Exchange Rate: Half Yearly (Aug 2013 – Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)
Introduction
Slide 5: Medical Diagnostics Sector – Overview
Market Overview
Slide 6: Medical Diagnostics– Market Overview Forecasted Market Size and Growth (Value-Wise; 2013 – 2018e)
Slide 7: Medical Diagnostics Market – Overview of Franchise Business Model
Slide 8: Medical Diagnostics Market – Overview of Other Business Models
Slide 9: Accreditation of Laboratories
Slide 10: Technological Developments Used for the Diagnosis of a Wide Spectrum of Infectious Diseases
Drivers & Challenges
Slide 11: Medical Diagnostics Market – Drivers and Challenges summary
Slide 12-16: Drivers
Slide 17-18: Challenges
Trends
Slide 19: Trends – Summary
Slide 20-22: Trends
Go
Letícia | Phone: 55 (21) 4009-0276 | E-mail: leticia@profarma.com.br
Market Maker: BTG Pactual | Phone: 55 (11) 3383-2384
Ticker: BM&FBOVESPA: PRMX3
Independent Auditors: KPMG
Thank you for your interest in Profarma. Please contact us if you have any other questions.
Healthcare Reform & Physician Loyalty: What Can CRM Do To Support ACOs?Perficient, Inc.
Martin Sizemore, Enterprise Architect at Perficient, and Lisa Anderson, CRM Solution Architect at Perficient, discuss Consumerism in Healthcare, Physician Practice Challenges & Alignment, and provide a Physician Loyalty Campaign Demo
The healthcare sector in India is governed by the Ministry of Health and Family Welfare. It has a total value of more than $40 billion and employs 8 million people directly and indirectly. Between 2000-2011, the sector grew by 9.8% annually. However, corporate hospitals constitute less than 1% of all healthcare institutes. An investment of $14.4 billion is needed by 2025 to increase India's bed density to at least two per thousand population.
MarketsandMarkets is a global market research firm that publishes strategically analyzed market research reports to help Fortune 500 companies make better business decisions. They offer a wide range of market research services including syndicated reports, consulting services, and custom research. MarketsandMarkets aims to provide actionable business insights into key industries to assist clients with sustainable growth.
The document is a 2012 study by CapSite on health information exchange (HIE). It provides an overview of study participants' profiles, current HIE adoption rates and recent technology investments, future investment plans, primary HIE vendors used, factors considered in vendor selection, and accountability care strategies. The appendix describes CapSite as a healthcare technology research and advisory firm that provides strategic industry reports, voice of customer research, and other solutions to help clients make informed decisions.
Innovation in medical device and diagnostic industry at India Leadership Conc...Indian Affairs
Conceptualized& instituted in the year by India’s most respected journalist Satya Brahma, India Leadership Conclave Awards are are meant to highlight & celebrate those individuals & companies who’ve ascended to the top of their business against all odds. Currently celebrating its 9th successful annual editions, iconic figures such as Ratata Tata, MukeshAmbani, Naresh Goyal, Narayan Murthy, Shiv Nadar,SudhaMurthy,Priyanka Chopra, Manish Malhotra, Neeta Lulla, Late Yash Chopra, Govinda, Rani Mukerjee, Sushimita Sen, Karishma Kapoor are some of its proud recipients. Being India’s most iconic leadership awards having a tremendous impact on the credibility of the Group, India Leadership Conclave jury takes every steps to ensure fair, credible & independent selection process,.The nomination categories, eligibility criteria, selection process & evaluation criteria constitute the core areas of research. Public voting constitutes its biggest parameters. Physical interviews by Network 7 Media Group Journalists on ground on each nominee are conducted followed by Jury’s strong analytical verdict. The set of awards developed by the Board Members of the Network 7 Media Group is to propel the talent engine & encourage, motivate the innovative entrepreneurs. These leadership awards are aimed at empowering the leaders who think differently.This recognition voted by the people of india& subsequent by Jury Board reflect the Winner’s remarkable achievement & accomplishments as a leader of substance driven by passion, initiative & commitment to deliver excellence. India Leadership Conclave Awards are special as we don’t follow any traditional guidelines, defy conventions & crown winners based on innovations, merit & competence. Our decision is based on number of factors which are transparent, robust & driven by extensive research.
Where Right Brain Meets Left: Translating for Medical and Pharmaceutical Mark...Erin Lyons
Medical and pharmaceutical marketing and promotional translation is a highly specialized discipline requiring scientific understanding and the agility and resourcefulness of a creative wordsmith. Translations must be accurate and intelligible, but they must also be engaging and work within the framework of an existing brand personality and advertising platform. Participants will be given an overview of advertising and promotional material (print, television, sales aids) and technical input (product monographs, patient brochures, production-related documents). Specific exercises and examples will explore interlinguistic wordplay, language-specific tone and voice, and production and regulatory constraints.
MediProbe Consultancy Services Pvt. Ltd. is an industry leading and pioneering Medical Intelligence Company specializing in Insurance Claims Verification and also active in other allied disciplines. We at MediProbe use top notch, seasoned investigators with years of experience in fraud investigation who leave no stone unturned in their quest to find and expose the truth. We have till date helped save insurance companies Millions of rupees- an astronomical sum they would have lost to fraudulent claims without Mediprobe. The key to this success is our belief in quality and performance and we are proud to have the highest ratio of fraud detection and denial of wrongful/fraudulent claims with concrete evidence. We are the investigator of choice for most Insurance Companies and leading TPAs operating in India. The fact that the number of claim investigations assigned to us has shot up from a measly 60 cases per month just a year ago to over 250 cases per month as of today speaks volumes about our quality and efficiency.
Bear Stearns 2003 Global Healthcare Conference Presentationfinance2
John Hammergren, CEO of McKesson Corporation, presented at the 2003 Bear Stearns Global Healthcare Conference. He outlined McKesson's mission to advance healthcare and success of its partners. McKesson offers comprehensive products and services across pharmaceutical distribution, medical supplies, automation technology, and clinical software. McKesson aims to leverage its size, customer base, and solutions to create value for customers and shareholders through improved quality, reduced costs, and sustained financial performance across its business segments.
Market Research Report : Catheterization laboratory market in india 2014 - Sa...Netscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract:
Netscribes’ latest market research report titled Catheterization Laboratory Market in India 2014 states that the Indian market for catheterization laboratories is growing steadily as a result of the advancements in technology and the resultant increase in demand from hospitals, nursing homes and other medical centers. Different segments are available in the market which includes the premium, performance and value segments. The rising incidence of cardiac diseases in the country and the increasing need for various medical procedures conducted in cath labs is however the most important growth factor for the market. Due to the growing target base, that is, healthcare centers, the market has huge potential for growth, thereby bringing immense benefit to players.
Several technological trends are visible in the market. With the rapid advancement and development of newer technologies, the market will get a further boost. Both domestic and foreign companies operate in the market and high competitive rivalry exists between them. However, Philips, GE and Siemens cumulatively hold the highest share in the market. The expansion of hospitals in tier II and tier III cities will help the Indian companies as these centers generally have a budget constraint and would prefer to buy the products of domestic manufacturers who generally sell their products at a lower price than those of foreign manufacturers.
Table of Contrnts:
The document summarizes the finance department of Fortis Hospital. It outlines the hierarchy and roles within the finance department, including preparing budgets, managing investments, and evaluating hospital performance. It also discusses the hospital's sources of revenue, operating and capital expenses, taxes paid, and key performance indicators like bed occupancy, average length of stay, and average revenue per occupied bed. The presentation provides an overview of the hospital's financial operations and metrics.
Market Research Report : Coronary stents market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract:
Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Table of Contents:
Saudi Arabia Diagnostic Labs Market, Forecast and Opportunities, 2027_Report.pdfMarcoBrown12
Saudi Arabia Diagnostic Labs market stood at USD1546.81 million in 2021 and is expected to grow at a steady CAGR of 6.79% during the forecast period.
For more information, click here: https://www.techsciresearch.com/report/saudi-arabia-diagnostic-labs-market/7937.html
Similar to Exir Redeka company profile new branding_2013 (20)
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
2. Business
in
Iran,
what
might
be
attractions ?
*
• Health
care
system
is
well
introduced
and
developed
• Less
legal
barriers
for
healthcare
professionals
is
selecting
their
needs.
• Less
availability
of
modern
tools
and
techniques
in
the
past.
• More
access
to
media
and
more
awareness
on
technology
of
the
day
by
all.
• More
number
of
consumers
than
most
of
the
well
established
markets
in
ME.
(75
million
population)
*
In
a
SWOT
context,
let’s
assume
this
defines
both
Strengths
and
Opportunities
although
different
in
nature.
3.
4. Business
in
Iran,
what
might
be
major
concerns*?
• Restricted
financial
transaction.
• Vulnerable
to
conflicts
• Not
high
per
capita
spend
on
healthcare
budget.
• Some
foreign
investors
might
be
reluctant
to
strongly
present.
• Intellectual
Property
rights
existing
but
not
to
its
general
terms.
• Central
control
over
pricing
and
healthcare
service
fees.
5. What
is
needed
today
is…
Category
and
Specialized
selling
competencies
beyond
other
factors.
It
is
inevitable
to
possess
such
abilities
and
skills
to
be
a
market
leader
and
stay
as
such.
Selling
skills
to
specialists
already
moved
from
its
traditional
style
into
“meeting
specialists
and
adding
value
to
their
knowledge,
handling
patients
and
squeezed
hectic
schedule”
Therefore
needs
transformed
to:
-‐ Specialized
Language
-‐ Specialized
Techniques
-‐ Specialized
Management
-‐ Specialized
Services
And
so
on…
6. Market
Segmentation
based
on
purchase
potential
Price
Quick Market Presence
Quality
Supply Continuity
Automation
Premium Service
Niche Market
7. Market
Segmentation
based
on
purchase
potential
We
divided
the
clients
40%
Institutions
Product
A
Into
4
major
target
groups:
This
is
based
on
their
potential
impact
on
sales:
35%
Private
Product
A
1-‐
Institutional
Labs.
2-‐
Privately
Established
.
3-‐
Pharmacies.
18%
Pharmacies
Product
A
4-‐
Research.
The
joint
marketing
strategy
can
be
utilized
by
shared
finance
and
mutual
promotional
packages
by
both
parties.
9. Tehran
top
performers
Product
A
Packs/Month
3,500
3,000
2,500
2,000
1,500
1,000
500
0
Tehran
total
est.~
22500
packs/month
latest
in
April
2012,
Data
by
Exir
Redeka
Ltd.
direct
collection
10. Provinces
Top
10
performers
Product
A
Packs/Month
4,500
4,000
3,500
3,000
2,500
2,000
1,500
1,000
500
0
Inst.
Lab.
Inst
Pvt.
Inst.
Inst.
Inst.
Pvt.
Pvt.
Inst.
Alzahra
Dr.
Mohajeri
Ghaem
Central
Cyto-‐Genetic
Namazi
Faghihi
Clinic
Dr.
Izadi
Lab.
All
other
All
other
Hospital
Lab.
Hospital
Pathology
Dept.
Medical
Hospital
provinces
provinces
Omid
Cance
Univ.
Hospital
Top
10
Provinces
top
performers
total
est.~
10300
Packs/Month
latest
in
April
2012,
Data
by
Exir
Redeka
Ltd.
direct
collection
11. Total
Packs
/
Month,
Tehran
+
Top
10
provinces
40,000
35,000
32,550
34,550
30,000
25,000
22,250
20,000
15,000
10,300
10,000
5,000
2,000
0
Tehran
Province
Tehran
+Provinces
All
other
RESEARCH
SUB
TOTAL
labs
NOT
in
the
list
Total
est.~
34500
Packs/Month
latest
in
April
2012,
Data
by
Exir
Redeka
Ltd.
direct
collection
*
Only
top
5
provinces
considered
13. Current
Market
Size
and
Main
Players
Market
Characterized
by:
• No
new
comer,
a
calm
market
for
those
existing
• Low
quality
service
• Long
delivery
time
and
unspecified
• Collecting
orders
for
each
Q
at
one
go.
• Collecting
cash
upon
delivery.
• No
marketing
essential
tools
-‐ Maintenance
by
technical
staff
on
trial
and
error
-‐
Low
English
proficiency
and
high
staff
turnover
15. Why
Exir
Redeka
Ltd.?
There
are
obvious
and
evidence
based
reasons
which
lies
behind
the
experience
of
the
management
and
their
level
of
specialized
knowledge.
-‐ More
than
15
years
of
experience
with
Multinationals
-‐ Managing
a
sales
revenue
of
80
USD
mio
or
so
annually
-‐ Managing
more
than
50
employees
and
building
specialized
teams
-‐ Understanding
the
brand
control
-‐ Expecting
the
unexpected,
others
usually
entrapped
in
-‐ Introducing
the
strongest
entry
channel
-‐ How
to
be
the
MoH
partner
of
choice
-‐ Optimizing
the
time-‐consuming
regulatory
process
when
possible
-‐ Launching
products
the
way
brings
long-‐term
values
for
both
parties
16. Import
and
distribution
diagram
at
a
glance
Supply
Chain
Scientific
and
Quality
MOH
Control
Medical
Equipment
Office
Pathology
Department
• Inspection
Toos
Hospital
• Pricing
• Licensing
Sales
Orders
Service
and
Maintenance
Field
visits
Distribution
to
Tehran
and
Provinces1
1
Distributor
for
Provinces
Province
Service
17. Strong
and
simple
business
analysis
and
forecasting
tools
any
shortage
can
kill!
We
are
using
simple
and
alarming
sheets
to
remind
us
the
order
gaps,
overstock,
highly
consumed
and
slow
moving
inventory
plus
many
other
information
we
might
be
in
need
of.
We
also
constantly
monitor
the
sales
behavior
of
the
products
against
activities
and
external
forces
in
order
to
find
out
and
prevent
any
disturbance
at
the
beginning
and
when
they
just
reacted
slightly
unusual.
We
always
enjoy
working
with
productive
systems
and
18. Fast
Local
Operation
Support
Specialized
Low
Cost